`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`————————————————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`————————————————
`
`MYLAN PHARMACEUTICALS INC., ACTAVIS
`LABORATORIES FL, INC., AMNEAL PHARMACEUTICALS LLC,
`AMNEAL PHARMACEUTICALS OF NEW YORK, LLC, DR. REDDY'S
`LABORATORIES, INC., DR. REDDY'S LABORATORIES, LTD.,
`SUN PHARMACEUTICALS INDUSTRIES, LTD.,
`SUN PHARMACEUTICALS INDUSTRIES, INC.,
`TEVA PHARMACEUTICALS USA, INC., WEST-WARD
`PHARMACEUTICAL CORP., and HIKMA PHARMACEUTICALS, LLC,
`
`Petitioners,
`
`v.
`
`JANSSEN ONCOLOGY, INC.,
`
`Patent Owner.
`
`————————————————
`Case IPR2016-013321
`Patent 8,822,438 B2
`
`————————————————
`
`REQUEST FOR ORAL ARGUMENT
`
`
`1 Case IPR2017-00853 has been joined with this proceeding.
`
`
`
`Pursuant to the Board’s Scheduling Orders, Petitioners respectfully request
`
`oral argument, currently scheduled for May 24, 2017.
`
`Pursuant to 37 C.F.R. § 42.70(a), Petitioners intend to argue the following
`
`issues:
`
`1. Any issues addressed by Petitioners, including in the Petition for Inter
`
`Partes Review and Reply in any of the proceedings, including whether any claim
`
`of U.S. Patent No. 8,822,438 is patentable.
`
`2. Any issues properly raised by Patent Owner, including in Patent Owner’s
`
`Response.
`
`3. Rebuttal to issues raised by Patent Owner.
`
`4. Petitioners’ motions to exclude evidence.
`
`5. Any motions to exclude evidence by Patent Owner.
`
`6. Any issues properly raised in Patent Owner’s Request for Oral Argument.
`
`Petitioners request that each side have 45 minutes for oral argument.
`
`Petitioners also request the ability to use audio/visual equipment to display
`
`demonstrative exhibits, including the use of a projector and screen for a
`
`PowerPoint presentation. Because of the number of anticipated attendees at the
`
`hearing, Petitioners request that the largest hearing room available be reserved for
`
`the hearing.
`
`
`
`1
`
`
`
`Dated: May 3, 2017
`
`
`
`
`
`
`
`/s/ Brandon M. White
`Brandon M. White
`Reg. No. 52,354
`Perkins Coie LLP
`700 13th St., NW, Suite 600
`Washington, D.C. 20005
`Telephone: (202) 654-6206
`E-mail: bmwhite@perkinscoie.com
`
`Counsel for Petitioner Mylan
`Pharmaceuticals Inc.
`
`2
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing Request for Oral
`
`Argument was served electronically via email as follows:
`
`Patent Owners:
`
`Dianne B. Elderkin
`Barbara L. Mullin
`Ruben H. Munoz
`Akin Gump Strauss Hauer & Feld LLP
`JANS-ZYTIGA@akingump.com
`
`Todd L. Krause
`David T. Pritikin
`Bindu Donovan
`Paul J. Zegger
`Sidley Austin LLP
`ZytigaIPRTeam@sidley.com
`
`
`
`Dated: May 3, 2017
`
`Petitioners:
`
`Samuel S. Park
`Jovial Wong
`Ryan B. Hauer
`Winston & Strawn LLP
`spark@winston.com
`jwong@winston.com
`rhauer@winston.com
`
`
`
`/s/ Brandon M. White
`Brandon M. White
`
`Counsel for Petitioner Mylan
`Pharmaceuticals Inc.
`
`1
`
`
`
`